tetano
Editor, Senior Moderator
Sci Rep
. 2023 Feb 2;13(1):1120.
doi: 10.1038/s41598-023-28006-3.
Association of combustible cigarettes and heated tobacco products use with SARS-CoV-2 infection and severe COVID-19 in Japan: a JASTIS 2022 cross-sectional study
Misako Nishimura[SUP] 1 [/SUP], Kazuhisa Asai[SUP] 2 [/SUP], Takahiro Tabuchi[SUP] 3 [/SUP], Erika Toyokura[SUP] 1 [/SUP], Takahiro Kawai[SUP] 1 [/SUP], Atsushi Miyamoto[SUP] 4 [/SUP], Tetsuya Watanabe[SUP] 4 [/SUP], Tomoya Kawaguchi[SUP] 4 [/SUP]
Affiliations
Abstract
Insufficient evidence has been accumulated regarding associations of heated tobacco products (HTPs) use with coronavirus infection and severity of coronavirus disease 2019 (COVID-19), an ongoing pandemic. We conducted a cross-sectional study using data from an internet questionnaire administered in February 2022 to 30,130 individuals from the general Japanese population (age range, 16-81 years). Single users of HTPs and dual users of combustible cigarettes and HTPs comprised 5.2% and 7.3% of respondents, and 6.7% and 38.0% of those infected (n = 1117). Approximately 70% of infected dual users experienced severe disease. Single users of HTPs and dual users were more likely to be infected with coronavirus than never-users (adjusted odds ratio [aOR] = 1.65/4.66; 95% confidence interval [CI] 1.26-2.15/3.89-5.58). Regarding severity, former and current tobacco users (former/combustible cigarettes/HTPs: aOR = 1.88/3.17/1.90; 95%CI 1.11-3.19/1.77-5.67/1.01-3.59) were more likely to be administered oxygen than never-users, and dual users required oxygen administration the most (aOR = 4.15, 95%CI 2.70-6.36). Use of HTPs may increase risks of coronavirus infection and severe COVID-19. Our results provide an opportunity to consider the safety of tobacco products use, including HTPs, during the COVID-19 pandemic.
. 2023 Feb 2;13(1):1120.
doi: 10.1038/s41598-023-28006-3.
Association of combustible cigarettes and heated tobacco products use with SARS-CoV-2 infection and severe COVID-19 in Japan: a JASTIS 2022 cross-sectional study
Misako Nishimura[SUP] 1 [/SUP], Kazuhisa Asai[SUP] 2 [/SUP], Takahiro Tabuchi[SUP] 3 [/SUP], Erika Toyokura[SUP] 1 [/SUP], Takahiro Kawai[SUP] 1 [/SUP], Atsushi Miyamoto[SUP] 4 [/SUP], Tetsuya Watanabe[SUP] 4 [/SUP], Tomoya Kawaguchi[SUP] 4 [/SUP]
Affiliations
- PMID: 36732559
- DOI: 10.1038/s41598-023-28006-3
Abstract
Insufficient evidence has been accumulated regarding associations of heated tobacco products (HTPs) use with coronavirus infection and severity of coronavirus disease 2019 (COVID-19), an ongoing pandemic. We conducted a cross-sectional study using data from an internet questionnaire administered in February 2022 to 30,130 individuals from the general Japanese population (age range, 16-81 years). Single users of HTPs and dual users of combustible cigarettes and HTPs comprised 5.2% and 7.3% of respondents, and 6.7% and 38.0% of those infected (n = 1117). Approximately 70% of infected dual users experienced severe disease. Single users of HTPs and dual users were more likely to be infected with coronavirus than never-users (adjusted odds ratio [aOR] = 1.65/4.66; 95% confidence interval [CI] 1.26-2.15/3.89-5.58). Regarding severity, former and current tobacco users (former/combustible cigarettes/HTPs: aOR = 1.88/3.17/1.90; 95%CI 1.11-3.19/1.77-5.67/1.01-3.59) were more likely to be administered oxygen than never-users, and dual users required oxygen administration the most (aOR = 4.15, 95%CI 2.70-6.36). Use of HTPs may increase risks of coronavirus infection and severe COVID-19. Our results provide an opportunity to consider the safety of tobacco products use, including HTPs, during the COVID-19 pandemic.